Literature DB >> 30266019

Formation and characterization of self-assembled bovine serum albumin nanoparticles as chrysin delivery systems.

Joana B Ferrado1, Adrián A Perez2, Flavia F Visentini2, Germán A Islan3, Guillermo R Castro3, Liliana G Santiago4.   

Abstract

Chrysin (5,7-dihydroxyflavone) (Chrys) is a natural flavone extracted from many plants, and it has been proposed as a bioactive agent for cancer therapy. Nevertheless, its use is limited mainly due to its poor water solubility. Bovine serum albumin (BSA) is a water soluble, biocompatible and non-toxic protein with a promising application in lipophilic bioactive compound delivery. Moreover, BSA is heat sensitive, feature that could be used for producing self-assembled nanoparticle with tailor-made properties. In this contribution, we studied the formation of BSA nanoparticles (BSAnp) by thermal treatment at different conditions of temperature (70 °C/5 min and 85 °C/5 min), protein concentration (1.0-4.0%wt.) and aqueous medium pH values (9.0 and 11.0) in which it is known that BSA is found in different unfolded conformations. Binding of Chrys dissolved in dimethyl sulfoxide (DMSO) was studied by fluorescence titration experiments. Characterization of Chrys-loaded and unloaded BSAnp was performed in phosphate buffered saline (PBS) pH 7.4 by applying a set of complementary techniques: dynamic light scattering (DLS), size exclusion fast protein liquid chromatography (SEC-FPLC) and transmission electron microscopy (TEM). Different populations of BSAnp were obtained, which showed different diameters in the range of 1328 nm, ζ potentials around -10.0 mV, molecular weight in the range of 400-1000 kDa and spherical shape. Chrys encapsulation efficiency (EE. %) was also determined, and values between 44-84% were obtained, which mainly depended on the mode of Chrys binding and physicochemical BSAnp properties. Results highlight the ability of self-assembled BSAnp for Chrys vehiculization in an aqueous medium which could found potential application in antitumor therapies.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bovine serum albumin; Chrysin; Heat treatment; Nanoparticle; Protein concentration; Self-assembly; pH

Mesh:

Substances:

Year:  2018        PMID: 30266019     DOI: 10.1016/j.colsurfb.2018.09.046

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  5 in total

1.  Encapsulation of epigallocatechin-3-gallate into albumin nanoparticles improves pharmacokinetic and bioavailability in rat model.

Authors:  Nithya Ramesh; Abul Kalam Azad Mandal
Journal:  3 Biotech       Date:  2019-05-28       Impact factor: 2.406

2.  Development, Optimization, and Pharmacokinetics Study of Bufalin/Nintedanib Co-loaded Modified Albumin Sub-microparticles Fabricated by Coaxial Electrostatic Spray Technology.

Authors:  Peng Chen; Shengzhe Lu; Bin Pan; Ying Xu
Journal:  AAPS PharmSciTech       Date:  2021-12-09       Impact factor: 3.246

Review 3.  Nanotechnology-Based Drug Delivery to Improve the Therapeutic Benefits of NRF2 Modulators in Cancer Therapy.

Authors:  Zerrin Sezgin-Bayindir; Sonia Losada-Barreiro; Carlos Bravo-Díaz; Matej Sova; Julijana Kristl; Luciano Saso
Journal:  Antioxidants (Basel)       Date:  2021-04-27

Review 4.  Functionalized Liposome and Albumin-Based Systems as Carriers for Poorly Water-Soluble Anticancer Drugs: An Updated Review.

Authors:  Sofia Teixeira; Maria Alice Carvalho; Elisabete M S Castanheira
Journal:  Biomedicines       Date:  2022-02-18

Review 5.  Broad-Spectrum Preclinical Antitumor Activity of Chrysin: Current Trends and Future Perspectives.

Authors:  Ebrahim Rahmani Moghadam; Hui Li Ang; Sholeh Etehad Asnaf; Amirhossein Zabolian; Hossein Saleki; Mohammad Yavari; Hossein Esmaeili; Ali Zarrabi; Milad Ashrafizadeh; Alan Prem Kumar
Journal:  Biomolecules       Date:  2020-09-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.